### Diabeloop's Innovations in Diabetes Management Diabeloop, a French med-tech company, is making significant strides in diabetes management with their new iController. This device is the core of a closed-loop system that integrates various diabetes devices to automate insulin delivery. The iController uses a smart algorithm to analyze glucose data from a continuous glucose monitor (CGM) and calculate the necessary insulin doses, which are then delivered via an insulin pump. One of the standout features of Diabeloop's system is its user-centric design. The company has collaborated closely with people with diabetes to create a system that is both practical and customizable. For instance, the system includes a “Zen Mode” that temporarily raises glucose targets to avoid frequent alerts, and a “Privacy Mode” to keep data confidential. The iController's algorithm is hosted on a dedicated smartphone app, which communicates with the insulin pump and CGM. This setup allows for real-time data analysis and insulin delivery adjustments every five minutes. The system also offers customizable glycemic targets and meal preferences, making it adaptable to individual needs. Diabeloop has already received European regulatory approval for its first-generation system and plans to launch it in Europe in 2021, with a U.S. launch to follow. The company is also working on a second-generation system, DBLG2, which aims to further simplify diabetes management. Overall, Diabeloop's iController represents a significant advancement in automated insulin delivery systems, offering a more personalized and user-friendly approach to diabetes care.